LUX Global Label

SDIX, a wholly owned subsidiary of OriGene Technologies, specializes in high-quality large-scale GMP antibody production, with operations in Delaware and Maine. With over 30 years of experience, the company is dedicated to developing innovative and results-oriented antibody-based solutions for the diagnostic and commercialization markets. Offering a wide range of IHC antibodies, IVD reagents, and custom formulation services, SDIX is committed to delivering superior performance, specificity, and quality. Their extensive capabilities in monoclonal and polyclonal antibody production enable them to address the diverse needs of clients in biotechnology and pharmaceutical industries. Generated from the website